Sonya N. Wright

Array ( [id] => 4185380 [patent_doc_number] => 06159962 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-12 [patent_title] => '3-substituted 3,4-dihydro-thieno[2,3-D]pyrimidine derivatives and production and use of the same' [patent_app_type] => 1 [patent_app_number] => 9/445222 [patent_app_country] => US [patent_app_date] => 1999-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3890 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/159/06159962.pdf [firstpage_image] =>[orig_patent_app_number] => 445222 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4254653 [patent_doc_number] => 06207822 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-27 [patent_title] => 'Process for the synthesis of azetidinones' [patent_app_type] => 1 [patent_app_number] => 9/455482 [patent_app_country] => US [patent_app_date] => 1999-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3515 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/207/06207822.pdf [firstpage_image] =>[orig_patent_app_number] => 455482 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1524073 [patent_doc_number] => 06353006 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-05 [patent_title] => 'Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents' [patent_app_type] => B1 [patent_app_number] => 09/453613 [patent_app_country] => US [patent_app_date] => 1999-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 63282 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 605 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/353/06353006.pdf [firstpage_image] =>[orig_patent_app_number] => 09453613 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1240208 [patent_doc_number] => 06686366 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-02-03 [patent_title] => 'Compounds specific to adenosine A3 receptor and uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/454075 [patent_app_country] => US [patent_app_date] => 1999-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38152 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/686/06686366.pdf [firstpage_image] =>[orig_patent_app_number] => 09454075 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1342823 [patent_doc_number] => 06586430 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-01 [patent_title] => 'CCR5 modulators' [patent_app_type] => B1 [patent_app_number] => 09/452578 [patent_app_country] => US [patent_app_date] => 1999-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43993 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/586/06586430.pdf [firstpage_image] =>[orig_patent_app_number] => 09452578 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 958852 [patent_doc_number] => 06953798 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-10-11 [patent_title] => 'β-alanine derivates' [patent_app_type] => utility [patent_app_number] => 09/450999 [patent_app_country] => US [patent_app_date] => 1999-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21442 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/953/06953798.pdf [firstpage_image] =>[orig_patent_app_number] => 09450999 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 758524 [patent_doc_number] => 07015322 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-03-21 [patent_title] => 'Process for producing carbamazepine' [patent_app_type] => utility [patent_app_number] => 09/447490 [patent_app_country] => US [patent_app_date] => 1999-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2195 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/015/07015322.pdf [firstpage_image] =>[orig_patent_app_number] => 09447490 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4326619 [patent_doc_number] => 06329366 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-11 [patent_title] => 'Pharmaceutical compounds' [patent_app_type] => 1 [patent_app_number] => 9/442904 [patent_app_country] => US [patent_app_date] => 1999-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15207 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/329/06329366.pdf [firstpage_image] =>[orig_patent_app_number] => 442904 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4383281 [patent_doc_number] => 06262046 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-17 [patent_title] => 'Azetidinylpropylpiperidine derivatives, intermediates and use as tachykinin antagonists' [patent_app_type] => 1 [patent_app_number] => 9/423771 [patent_app_country] => US [patent_app_date] => 1999-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14156 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 497 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/262/06262046.pdf [firstpage_image] =>[orig_patent_app_number] => 423771 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4409962 [patent_doc_number] => 06265416 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-24 [patent_title] => 'Antithrombotic agents' [patent_app_type] => 1 [patent_app_number] => 9/429424 [patent_app_country] => US [patent_app_date] => 1999-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9971 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 299 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/265/06265416.pdf [firstpage_image] =>[orig_patent_app_number] => 429424 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1401595 [patent_doc_number] => 06531605 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-11 [patent_title] => 'Process for the manufacture of arylsulfonyl chloride' [patent_app_type] => B1 [patent_app_number] => 09/380478 [patent_app_country] => US [patent_app_date] => 1999-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3364 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/531/06531605.pdf [firstpage_image] =>[orig_patent_app_number] => 09380478 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1253592 [patent_doc_number] => 06670366 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-12-30 [patent_title] => 'Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction' [patent_app_type] => B1 [patent_app_number] => 09/426552 [patent_app_country] => US [patent_app_date] => 1999-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22577 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 857 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/670/06670366.pdf [firstpage_image] =>[orig_patent_app_number] => 09426552 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4157003 [patent_doc_number] => 06114327 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-05 [patent_title] => 'Anti-viral compounds' [patent_app_type] => 1 [patent_app_number] => 9/425093 [patent_app_country] => US [patent_app_date] => 1999-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14662 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/114/06114327.pdf [firstpage_image] =>[orig_patent_app_number] => 425093 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4307190 [patent_doc_number] => 06252080 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-26 [patent_title] => '8-hydroxy-7-substituted quinolines as anti-viral agents' [patent_app_type] => 1 [patent_app_number] => 9/425564 [patent_app_country] => US [patent_app_date] => 1999-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21938 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 394 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/252/06252080.pdf [firstpage_image] =>[orig_patent_app_number] => 425564 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1384292 [patent_doc_number] => 06552029 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-22 [patent_title] => '2-pyrimidineamine derivatives and processes for their preparation' [patent_app_type] => B1 [patent_app_number] => 09/420755 [patent_app_country] => US [patent_app_date] => 1999-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17950 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/552/06552029.pdf [firstpage_image] =>[orig_patent_app_number] => 09420755 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4410609 [patent_doc_number] => 06239277 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-29 [patent_title] => 'Process for preparing piperazine-substituted aliphatic carboxylates' [patent_app_type] => 1 [patent_app_number] => 9/421514 [patent_app_country] => US [patent_app_date] => 1999-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3154 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/239/06239277.pdf [firstpage_image] =>[orig_patent_app_number] => 421514 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4321014 [patent_doc_number] => 06248781 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-19 [patent_title] => 'Compounds useful in the treatment of conditions mediated by peroxisome proliferator-activated receptors (PPAR)' [patent_app_type] => 1 [patent_app_number] => 9/419864 [patent_app_country] => US [patent_app_date] => 1999-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32463 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1161 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/248/06248781.pdf [firstpage_image] =>[orig_patent_app_number] => 419864 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4396583 [patent_doc_number] => 06297226 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-02 [patent_title] => 'Synthesis and methods of use of 9-substituted guanine derivatives' [patent_app_type] => 1 [patent_app_number] => 9/419153 [patent_app_country] => US [patent_app_date] => 1999-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11215 [patent_no_of_claims] => 123 [patent_no_of_ind_claims] => 49 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/297/06297226.pdf [firstpage_image] =>[orig_patent_app_number] => 419153 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4329063 [patent_doc_number] => 06319928 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-20 [patent_title] => 'Purine derivatives having phosphodiesterase IV inhibition activity' [patent_app_type] => 1 [patent_app_number] => 9/418331 [patent_app_country] => US [patent_app_date] => 1999-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20281 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 147 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/319/06319928.pdf [firstpage_image] =>[orig_patent_app_number] => 418331 [rel_patent_id] =>[rel_patent_doc_number] =>)